Exosomes derived from bone marrow mesenchymal stem cells target FOXO1 via miR-183 to reduce apoptosis and oxidative stress in ischemia/reperfused cardiomyocytes, thereby improving cardiac function and preventing myocardial ischemia/reperfusion (MI/R) injury [45]. This evidence concerns the gene FOXO1 and myocardial ischemia.